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Abstract
Acute pancreatitis is caused by alcohol, gall stone disease, drugs, trauma, infections, and metabolic causes such as hypercalcemia
and hyperlipidemia. Hypercalcemia-induced acute pancreatitis has been well documented but only rarely occurs due to overthe-counter calcium carbonate. In this article, we present a case of over-the-counter calcium carbonate–induced acute
pancreatitis.
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Introduction
Acute pancreatitis is defined as inflammation of the pancreas
and is one of the common reasons for hospital admissions in
the United States.1 It has multiple causes, with alcohol and
gall stone disease contributing to 80% to 90% of cases.2
Other reported causes include drugs, common bile duct
obstructions secondary to neoplasms and sphincter of Oddi
dysfunction, and metabolic alterations such as hypercalcemia or hypertriglyceridemia. Hypercalcemia associated with
primary hyperparathyroidism contributes to 3.6% cases of
pancreatitis cases, while pancreatitis induced by excess consumption of over-the-counter (OTC) calcium carbonate is
rare and very seldom reported in the literature.3,4 In this article, we present the case of a young male with pancreatitis
secondary to OTC calcium carbonate medications.

Case Description
A 35-year-old male with no significant past medical history
was admitted for epigastric pain with radiation to the back
associated with nausea and vomiting. He complained of
fatigue, poor appetite, and increased urination. He had a history of gastroesophageal reflux disease for which he was taking OTC medications. His vital signs were stable. On
examination, he appeared slightly confused, with dry skin
and generalized abdominal tenderness. Blood work: white
blood cells 16 400/µL, sodium 139 mmol/L, blood urea nitrogen 23 mg/dL, creatinine 2.6 mg/dL, aspartate aminotransferase 34 U/L, alanine aminotransferase 26 U/L, bicarbonate
34 mmol/L, alkaline phosphatase 114 U/L, calcium 15.1 mg/
dL, triglyceride level 79 mg/dL, low-density lipoprotein 110

mg/dL, lipase 560 U/L, albumin 3.9 g/dL, and negative for
ethanol. Computed tomography scan of abdomen/pelvis
showed pancreatitis with a normal biliary tract. He was
treated with pain medications and ringer lactate fluid.
Further investigation showed low parathyroid hormone
(PTH) = 18 pg/mL, low vitamin D (25) = 17 ng/mL, along
with normal PTH-related peptide, vitamin D (1,25), serum
protein electrophoresis, urine protein electrophoresis, and
free light chain. The patient admitted that he had been taking
7 to 8 tablets of 600 mg calcium carbonate per day over the
past 3 weeks for acid reflux. His symptoms and calcium level
gradually improved with ringer lactate, and he was discharged after 6 days. He was educated on the side effects of
excessive OTC drug use.

Discussion
Milk-alkali syndrome (MAS) is caused by increased consumption of calcium and alkali products. MAS is characterized by the triad of hypercalcemia, renal failure, and
metabolic alkalosis. Increased use of OTC drugs in patients
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with osteoporosis and kidney failure can lead to a life-threatening illness. In the early days after its discovery, MAS was
associated with an increased mortality rate of 4.4%.5 MAS
was first described by Hardt and Rivers in 1923.6 They attributed this syndrome to the Sippy regimen, which was developed in 1915 for peptic ulcer disease. The Sippy regimen
comprised the hourly consumption of milk, cream, and a
mixture of alkaline powders. Prior to the discovery of H2
blockers and proton pump inhibitors, the Sippy regimen was
commonly used in peptic ulcer disease.7 In the 1970s and
1980s, MAS contributed to less than 2% of hospitalized
patients with hypercalcemia, but this incidence has increased
to 12% in recent years.8 MAS is now considered to be the
third most common cause of hypercalcemia, after hyperparathyroidism and malignant neoplasms. Some authors have
suggested that this increased incidence is due to increased
use of OTC drugs.9
The pathophysiology of MAS is classified into 2 phases:
a generation phase and a maintenance phase. Excess calcium
consumption increases serum calcium levels; this results in
volume depletion from diuresis and natriuresis by activation
of the calcium sensing receptor (CaSR), which stimulates
renal tubular absorption of bicarbonate and decreases glomerular filtration rate. This decreased glomerular filtration
rate reduces filtration of calcium, while volume depletion
and metabolic alkalosis lead to increased renal absorption of
calcium in order to maintain calcium homeostasis. The
pathophysiology of hypercalcemia-induced pancreatitis is
unclear, but high calcium levels are thought to lead to intracellular activation of proteases.10-13 In addition to OTC drugs
as an inciting factor for MAS, other cyclic pathophysiologic
pathways that promote alkalosis, hypercalcemia, and renal
failure can mimic MAS. MAS has been reported with the
consumption of more than 4 to 5 g of calcium carbonate per
day.9 These cases present in 3 forms: acute, subacute (cope
syndrome), and chronic (Burnett syndrome).14 In the acute
phase, patients present with symptoms of toxemia, such as
nausea, vomiting, anorexia, dizziness, vertigo, and confusion; and in chronic phase, they present with muscle aches,
polyuria, polydipsia, psychosis, tremor, pruritis, and abnormal calcifications. Ocular calcification, renal calcinosis, and
rarely breast calcifications have been reported.15 The diagnosis is clinical, and a detailed history along with a physical can
aid the diagnosis of MAS. Treatment is mostly supportive,
with hydration and removal of the underlying causative
agent.
According to the evidence discussed above, we conclude
that medications should be reconciled on every patient
encounter, including OTC medications, and patients should
be educated about the side effects of excessive use. Daily
elemental calcium intake should not exceed 2 g per day.
However, MAS has also been reported with a lower calcium
intake in patients on thiazides and with preexisting renal failure, as in our patient. Therefore, it is very important that all
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patients should be educated on various drug interactions in
addition to information about daily calcium intake.
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